Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 249-934-2 | CAS number: 29895-73-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin irritation / corrosion
Administrative data
- Endpoint:
- skin corrosion: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 11 May 2016 to 13 May 2016
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 016
- Report date:
- 2016
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 431 (In Vitro Skin Corrosion: Reconstructed Human Epidermis (RHE) Test Method)
- Version / remarks:
- 28 July 2015
- GLP compliance:
- yes (incl. QA statement)
Test material
- Reference substance name:
- Benzeneacetaldehyde, cyclic acetal with glycerol
- EC Number:
- 249-934-2
- EC Name:
- Benzeneacetaldehyde, cyclic acetal with glycerol
- Cas Number:
- 29895-73-6
- Molecular formula:
- C11H14O3
- IUPAC Name:
- Reaction mass of cis-2-benzyl-1,3-dioxan-5-ol and rel-[(2R,4R)-2-benzyl-1,3-dioxolan-4-yl]methanol and rel-[(2R,4S)-2-benzyl-1,3-dioxolan-4-yl]methanol and trans-2-benzyl-1,3-dioxan-5-ol
- Test material form:
- liquid
1
In vitro test system
- Test system:
- human skin model
- Source species:
- human
- Cell type:
- other: target cells are epithelial, derived from human skin, and formed into a stratified, cornified epithelium.
- Cell source:
- other: MatTek
- Vehicle:
- unchanged (no vehicle)
- Details on test system:
- TEST SYSTEM
EpiDerm™ Reconstructed Human Epidermis Model Kit:
Supplier: MatTek
Date received: 10 May 2016
EpiDermTM Tissues (0.63cm2) lot number: 23335
Assay Medium lot number: 050516TMA
Upon receipt of the EpidermTM tissues, the sealed 24-well plate was stored in a refrigerator until use.
STUDY DESIGN
PRE-TEST PROCEDURE:
Assessment of Direct Test Item Reduction of MTT:
MTT Dye Metabolism, Cell Viability Assay:
The MTT assay, a colorimetric method of determining cell viability, is based on reduction of the yellow tetrazolium salt (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl-tetrazolium bromide) to a blue formazan dye by mitochondrial succinate dehydrogenase in viable cells.
One limitation of the assay is possible interference of the test item with MTT. A test item may directly reduce MTT, thus mimicking dehydrogenase activity of the cellular mitochondria. This property of the test item is only a problem if at the time of the MTT test (after rinsing) there is still a sufficient amount of the test item present on or in the tissues. In this case, the true metabolic MTT reduction and the false direct MTT reduction can be differentiated and quantified.
Test for Direct MTT Reduction:
As specified, a test item may interfere with the MTT endpoint, if it was able to directly reduce MTT and at the same time was present on or in the tissues when the MTT viability test was performed. To identify this possible interference, the test item was checked for the ability to directly reduce MTT according to the procedure below:
50 µL of the test item was added to 1 mL of a freshly prepared 1.0 mg/mL MTT solution. The solution was incubated in the dark at 37 °C, 5% CO2 in air for 60 minutes. Untreated MTT solution was tested concurrently to act as a control.
If the MTT solution containing the test item turns blue or purple relative to the control, the test item was presumed to have reduced the MTT.
The test item was found to be a possible direct reducer of MTT in the direct MTT reduction test. There was a possibility that if the test item could not be totally rinsed off the tissues, any residual test item present on or in the tissue may directly reduce MTT and could have given rise to a false negative result. Therefore, the determination of skin corrosion potential was performed in parallel on viable and freeze- killed tissues.
This step was a functional check which employs freeze-killed tissues that possess no metabolic activity but absorb and bind the test item like viable tissues.
Freeze-killed tissues were prepared by placing untreated EPIDERM tissues in an empty 12 well plate and storing in a freezer (-14 to -30 °C) for a minimum of 24 hours. Before use each tissue was thawed by placing in 0.9 mL of assay medium for approximately 1 hour at room temperature.
In addition to the normal test procedure, the MTT reducing test item was applied to two freeze killed tissues per exposure period. In addition, two freeze killed tissues per exposure period remained untreated. The untreated freeze killed control showed a small amount of MTT reduction due to residual reducing enzymes within the killed tissues.
Assessment of Color Interference with the MTT Endpoint:
A test item may interfere with the MTT endpoint if it is colored. The MTT assay is affected only if the test item is present in the tissues when the MTT viability assay is performed.
50 µL of test item was added to 300 µL of sterile water. The solution was incubated in the dark at 37 oC, 5% CO2 in air for 60 minutes. A visual assessment of the color was then made.
MAIN TEST
Pre-Incubation:
The assay medium was pre-warmed before use. 0.9 mL of this assay medium was pipetted into the appropriate wells of two pre-labeled 6-well plates for both the 3-Minute and 60-Minute exposure periods. EpiDerm™ tissues were transferred into the 6-well plates containing the assay medium. The 6-well plates containing the EpiDerm™ samples were pre-incubated (37 °C, 5% CO2) for approximately 1 hour before dosing.
Application of Test Item and Rinsing:
Before pre-incubation was complete, a 24-well plate was prepared for use as a “holding plate” for both the 3-Minute and 60-Minute exposure periods. This plate was used to maintain the viability of the tissue inserts between rinsing following chemical exposure and MTT loading. Another 24-well plate was prepared for the MTT loading. 300 µL of either pre-warmed assay medium (holding plate) or MTT medium (MTT loading plate) was dispensed into each well. The two plates were placed into the incubator until required.
After pre-incubation of the EpiDerm™ tissues, the medium was aspirated and replaced with 0.9 mL of fresh assay medium. The 6-well plate for the 3-Minute exposure period was returned to the incubator, while the other was being dosed for the 60-Minute exposure. For the 60-Minute exposure period, 50 µL of sterile distilled water (negative control) was added to the first two tissues. The tissues were dosed at regular intervals to allow for the time taken to rinse each tissue following exposure and to ensure that each tissue gets an equal exposure time. 50 µL of the test item and 50 µL of 8.0 N Potassium Hydroxide (positive control) were also applied to the corresponding tissues in turn. The plate was returned to the incubator (37 °C, 5% CO2) for the 60-Minute exposure period.
When dosing for the 60-Minute exposure period was complete, the same procedure was repeated for the 3-Minute exposure period. Because the exposure time was so short, the tissues were dosed at regular intervals to ensure that each tissue received an equal exposure time and to allow for the time taken to rinse each tissue following exposure. Rinsing was achieved by filling and emptying each tissue under a constant soft stream of DPBS to gently remove any residual test item. Excess DPBS was removed by blotting the bottom of the tissue insert with tissue paper. Each tissue was placed into the prepared holding plate until all tissues were rinsed. They were then blotted and transferred to the 24-well plate prepared for MTT loading. The plate was incubated (37 °C, 5% CO2) for 3 hours. Once the 60-Minute exposure period was complete, the same rinsing and MTT loading procedure was repeated.
After the 3-Hour MTT incubation was complete, the inserts were blotted and transferred to labeled 24-well plates for MTT extraction. 2 mL of MTT extractant (isopropanol) was used to completely immerse each insert and the plate was covered with plate sealer to prevent Isopropanol evaporation. The plates stood overnight at room temperature, to allow extraction to proceed.
Absorbance/Optical Density Measurements:
After extraction, each tissue was pierced with a pipette fitted with a 1000 µL tip and the extraction solution was forced vigorously up and down to form a homogenous solution. 3 x 200 µL aliquots of the extract were transferred to the appropriate wells of a pre-labeled 96-well plate. 200 µL of isopropanol alone was added to the three wells designated as blanks. Absorbency at 562nm (OD562) of each well was measured using the Anthos 2001 microplate reader.
DATA EVALUATION
Quantitative MTT Assessment (percentage tissue viability):
The corrosivity potential of the test item was predicted from the relative mean tissue viabilities obtained after the 3 and 60-Minute exposure periods, compared to the mean of the negative control tissues (n=2) treated with sterile distilled water. The relative mean viabilities were calculated in the following way:
Relative mean viability (%) = (mean OD562 of test item / mean OD562 of negative control) x 100
Classification of corrosivity potential is based on relative viabilities for both exposure times according to the table presented under Any other information on materials and methods incl. tables.
QUALITY CRITERIA
The results of the assay are considered acceptable if the following assay acceptance criteria are achieved:
Negative Control: The absolute OD562 of the negative control treated tissues in the MTT-test is an indicator of tissue viability obtained in the testing laboratory after the shipping and storing procedure and under specific conditions of the assay. The mean OD562 of the two negative control tissues should be ≥ 0.8 and ≤ 2.8 for each exposure time, which ensures that the tissue viability meets the acceptance criteria.
Positive Control: Potassium Hydroxide 8.0N solution is used as a positive control. An assay meets the acceptance criterion if mean relative tissue viability of the 60 minute positive control is < 15%.
Coefficient of Variation: In the range 20 and 100% viability, the Coefficient of Variation between tissue replicates should be ≤ 30%. - Control samples:
- yes, concurrent negative control
- yes, concurrent positive control
- Amount/concentration applied:
- 50 µL
- Duration of treatment / exposure:
- 3-Minute exposure period and 60-Minute exposure period
- Duration of post-treatment incubation (if applicable):
- 3 hours MTT incubation period and overnight MTT extraction period
- Number of replicates:
- 2
Results and discussion
In vitro
Resultsopen allclose all
- Irritation / corrosion parameter:
- % tissue viability
- Run / experiment:
- 3-Minute exposure period
- Value:
- 87.7
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- other: Relative mean tissue viability compared to the negative control tissues (viability set at 100%)
- Irritation / corrosion parameter:
- % tissue viability
- Run / experiment:
- 60-Minute exposure period
- Value:
- 67.6
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- other: Relative mean tissue viability compared to the negative control tissues (viability set at 100%)
- Other effects / acceptance of results:
- Direct MTT Reduction:
The test item was found to be a possible direct reducer of MTT. Therefore, an additional procedure using freeze-killed tissues was performed during the determination of skin corrosion potential as a precaution. However, the results obtained showed a negligible degree of interference due to direct reduction of MTT occurred. It was therefore considered unnecessary to use the results of the freeze-killed tissues for quantitative correction of results. The results generated from the freeze-killed tissues are presented below.
3 minutes exposure:
Mean of test item treated killed tissues (tkt) = 0.147 OD562
Mean of untreated killed tissues (ukt) = 0.139 OD562
The direct reduction by the test item relative to the negative control value:
(0.147 (tkt) – 0.139 (ukt)) / 1.858 (mean of negative control) = 0.4%
60 minutes exposure:
Mean of test item treated killed tissues (tkt) = 0.143 OD562
Mean of untreated killed tissues (ukt) = 0.136 OD562
The direct reduction by the test item relative to the negative control value:
(0.143 (tkt) – 0.136 (ukt)) / 1.669 (mean of negative control) = 0.4%
Assessment of Color Interference with the MTT endpoint:
The solution (sterile water) containing the test item did not become colored. This was taken to indicate the test item did not have the potential to cause color interference.
Test Item, Positive Control Item and Negative Control Item:
Mean OD562 values and viabilities for the negative control, positive control and test item are given under Any other information on results incl. tables.
Quality Criteria
The mean OD562 for the negative control treated tissues was 1.858 for the 3-Minute exposure period and 1.669 for the 60-Minute exposure period. The negative control acceptance criteria were therefore satisfied.
The relative mean tissue viability for the positive control treated tissues was 4.5% relative to the negative control following the 60-Minute exposure period. The positive control acceptance criterion was therefore satisfied.
In the range 20 to 100% viability the Coefficient of Variation between the two tissue replicates of each treatment group did not exceed 30%. The acceptance criterion was therefore satisfied.
Any other information on results incl. tables
Mean OD562Values and Viabilities for the Negative Control Item, Positive Control Item and Test Item
Tissue |
Exposure Period |
MeanOD562of individual tissues |
Mean OD562of duplicate tissues |
Standard Deviation |
Coefficient of Variation (%) |
Relative Mean Viability (%) |
Negative Control |
3 Minutes |
2.030 |
1.858 |
0.243 |
13.1 |
100* |
1.686 |
||||||
60 Minutes |
1.676 |
1.669 |
0.010 |
0.6 |
||
1.662 |
||||||
Positive Control |
3 Minutes |
0.096 |
0.094 |
0.003 |
na |
5.1 |
0.092 |
||||||
60 Minutes |
0.086 |
0.075 |
0.016 |
na |
4.5 |
|
0.063 |
||||||
Test Item |
3 Minutes |
1.705 |
1.630 |
0.106 |
6.5 |
87.7 |
1.555 |
||||||
60 Minutes |
0.994 |
1.128 |
0.189 |
16.7 |
67.6 |
|
1.261 |
OD =Optical density
*= The mean % viability of the negative control tissue is set at 100%
na= Not applicable
Applicant's summary and conclusion
- Interpretation of results:
- other: Non-corrosive to the skin
- Remarks:
- in accordance with EU CLP and its amendents (1272/2008 and its amendments)
- Conclusions:
- The test item was considered to be non-corrosive to the skin, because the viability exceeded 50% after 3 min exposure (87.7%) and 15% after 60 min exposure (67.6%).
- Executive summary:
The corrosivity potential of the test item was evaluated using the EpiDerm™ Human Skin Model according to OECD TG 431 and GLP principles. Duplicate tissues were treated with the test item for exposure periods of 3 and 60 minutes. Negative and positive control groups were treated for each exposure period. The test item was found to be a possible direct reducer of MTT and therefore additional freeze-killed tissues were incorporated into the testing for correction purposes. However, the results obtained showed a negligible degree of interference due to direct reduction of MTT occurred (direct reduction by the test item relative to the negative control value is 0.4%). It was therefore considered unnecessary to use the results of the freeze-killed tissues for quantitative correction of results. The relative mean viability for test item treated tissues after 3-Minute and 60-Minute exposure period was 87.7% and 67.6%, respectively. The test item was considered to be non-corrosive to the skin, because the viability exceeded 50% after 3 min exposure and 15% after 60 min exposure. The mean OD562 for the negative control treated tissues after 3-Minute and 60-Minute exposure period was 1.858 and 1.669, respectively (acceptance criteria ≥ 0.8 and ≤ 2.8). The relative mean tissue viability for the positive control treated tissues was 4.5% relative to the negative control following the 60-Minute exposure period (<15%). In the range 20 to 100% viability the Coefficient of Variation between the two tissue replicates of each treatment group ranged between 0.6 and 16.7% (=<30%). The quality criteria required for acceptance of results in the test were satisfied.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.